Patrizio Panelli

Patrizio Panelli

Auto-generated profile, based on publicly available information

Patrizio Panelli

Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Cancer Letters
Verified
Journal Article
Closed access
SVSantina Venuto
Santina Venuto
LMLaura Monteonofrio
Laura Monteonofrio
FCflora cozzolino
flora cozzolino
Maria MontiMaria Monti
Maria Monti
IAIrene Appolloni
Irene Appolloni
LMLucia Micale
Lucia Micale

26 November 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CGC. Grasselli
C. Grasselli
ACAnnalucia Carbone
Annalucia Carbone
PPP. Panelli
P. Panelli
VGVincenzo Giambra
Vincenzo Giambra
MBM. Bossi
M. Bossi
LFLidia De Filippis
Lidia De Filippis

1 November 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
VGVincenzo Giambra
Vincenzo Giambra
SGSamuel Gusscott
Samuel Gusscott
DGDeanne Gracias
Deanne Gracias
RSRaymond Song
Raymond Song
SLSonya H. Lam
Sonya H. Lam
AWAndrew P. Weng
Andrew P. Weng

30 March 2023 in Blood
Verified
Journal Article
Open access
PDF file
PPPatrizio Panelli
Patrizio Panelli
ESElisabetta De Santis
Elisabetta De Santis
MCMattia Colucci
Mattia Colucci
FTFrancesco Tamiro
Francesco Tamiro
FSFrancesca Sansico
Francesca Sansico
VGVincenzo Giambra
Vincenzo Giambra
T-cell acute lymphoblastic leukemia (T-ALL) is a T-cell malignancy characterized by cell subsets and enriched with leukemia-initiating cells (LICs). β-Catenin modulates LIC activity in T-ALL. However, its role in maintaining established leukemia stem cells remains largely unknown. To identify functionally relevant protein interactions of β-catenin in T-ALL, we performed coimmunoprecipitation followed by liquid chromatography–mass spectrometry. Here, we report that a noncanonical functional interaction of β-catenin with the Forkhead box O3 (FOXO3) transcription factor positively regulates LIC-related genes, including the cyclin-dependent kinase 4, which is a crucial modulator of cell cycle and tumor maintenance. We also confirm the relevance of these findings using stably integrated fluorescent reporters of β-catenin and FOXO3 activity in patient-derived xenografts, which identify minor subpopulations with enriched LIC activity. In addition, gene expression data at the single-cell level of leukemic cells of primary patients at the time of diagnosis and minimal residual disease (MRD) up to 30 days after the standard treatments reveal that the expression of β-catenin– and FOXO3-dependent genes is present in the CD82+CD117+ cell fraction, which is substantially enriched with LICs in MRD as well as in early T-cell precursor ALL. These findings highlight key functional roles for β-catenin and FOXO3 and suggest novel therapeutic strategies to eradicate aggressive cell subsets in T-ALL.
1

1 February 2013 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
DPDamiano Panelli
Damiano Panelli
FLFrancesca Paola Lorusso
Francesca Paola Lorusso
FPFrancesco Papa
Francesco Papa
PPPatrizio Panelli
Patrizio Panelli
ASAlessandro Stella
Alessandro Stella
SPSergio Papa
Sergio Papa

27 June 2019 in Human Mutation
Verified
Journal Article
Closed access
PDF file
SMSilvia Morlino
Silvia Morlino
ACAnnalucia Carbone
Annalucia Carbone
Marco RitelliMarco Ritelli
Marco Ritelli
CFCarmela Fusco
Carmela Fusco
VGVincenzo Giambra
Vincenzo Giambra
LMLucia Micale
Lucia Micale